TRAW · Traws Pharma Inc. Common Stock
View on chartInsiders & Stakes
| ORBIMED ADVISORS LLC Director | ▲ Buy | Open Market | 1,203,250 Shares held | 4/16/2026 | View profile |
| Dukes Iain D. Director | ▲ Buy | Grant | 171,130 Shares held | 12/12/2025 | View profile |
| Savchuk Nikolay Chief Operating Officer | ▲ Buy | Grant | 150,606 Shares held | 12/12/2025 | View profile |
| Pauza Charles David Chief Science Officer Virology | ▲ Buy | Grant | 115,971 Shares held | 12/12/2025 | View profile |
| Redfield Robert Acting Chief Medical Officer | ▲ Buy | Grant | 113,919 Shares held | 12/12/2025 | View profile |
| CAUTREELS WERNER Chief Executive Officer | ▲ Buy | Grant | 109,222 Shares held | 12/12/2025 | View profile |
| Fruchtman Steven M President, Chief Executive Off | ▼ Sell | Tax Withholding | 74,792 Shares held | 3/14/2024 | View profile |
| Guerin Mark Patrick CFO AND COO | ▼ Sell | Tax Withholding | 39,255 Shares held | 6/18/2024 | View profile |
| OLER ABRAHAM N. SVP Corp Dev & Gen Counsel | ▲ Buy | Open Market | 24,514 Shares held | 1/28/2022 | View profile |
| MARINO JAMES J Director | ▲ Buy | Open Market | 21,334 Shares held | 9/28/2021 | View profile |
| Parker Charles Nolan Chief Financial Officer | ▲ Buy | Grant | 15,393 Shares held | 12/12/2025 | View profile |
| Gelder Mark S. MD Chief Medical Officer | ▼ Sell | Tax Withholding | 10,487 Shares held | 2/7/2023 | View profile |
| Shoemaker Mary Teresa | ▲ Buy | Grant | 6,292 Shares held | 12/12/2025 | View profile |
| STOVER JACK E Director | ▲ Buy | Grant | 6,165 Shares held | 12/12/2025 | View profile |
| Clarke Trafford | ▲ Buy | Grant | 6,157 Shares held | 12/12/2025 | View profile |
| Leaman John Harold | ▲ Buy | Grant | 4,058 Shares held | 12/12/2025 | View profile |
| TPAV, LLC 10% Owner | ▼ Sell | Other | 0 Shares held | 4/2/2025 | View profile |
Transaction History
| ORBIMED ADVISORS LLC | ▲ Buy | Open Market | 597,729 | $998K | 4/16/2026 |
| STOVER JACK E | ▲ Buy | Grant | 6,157 | $0 | 12/12/2025 |
| Dukes Iain D. | ▲ Buy | Grant | 36,943 | $0 | 12/12/2025 |
| Clarke Trafford | ▲ Buy | Grant | 6,157 | $0 | 12/12/2025 |
| Parker Charles Nolan | ▲ Buy | Grant | 15,393 | $0 | 12/12/2025 |
| Shoemaker Mary Teresa | ▲ Buy | Grant | 6,157 | $0 | 12/12/2025 |
| CAUTREELS WERNER | ▲ Buy | Grant | 4,874 | $0 | 12/12/2025 |
| Leaman John Harold | ▲ Buy | Grant | 4,058 | $0 | 12/12/2025 |
| Pauza Charles David | ▲ Buy | Grant | 18,471 | $0 | 12/12/2025 |
| Redfield Robert | ▲ Buy | Grant | 16,419 | $0 | 12/12/2025 |
| Savchuk Nikolay | ▲ Buy | Grant | 16,419 | $0 | 12/12/2025 |
| TPAV, LLC | ▼ Sell | Other | 605,531 | — | 4/2/2025 |
| CAUTREELS WERNER | ▲ Buy | Option Exercise | 96,348 | $963 | 2/18/2025 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 2,221 | $1K | 6/18/2024 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 5,500 | — | 6/10/2024 |
| Dukes Iain D. | ▲ Buy | Grant | 67,550 | — | 4/1/2024 |
| Dukes Iain D. | ▲ Buy | Grant | 1,645,100 | — | 4/1/2024 |
| Dukes Iain D. | ▲ Buy | Grant | 66,687 | — | 4/1/2024 |
| Savchuk Nikolay | ▲ Buy | Grant | 1,645,100 | — | 4/1/2024 |
| Savchuk Nikolay | ▲ Buy | Grant | 66,687 | — | 4/1/2024 |
| Savchuk Nikolay | ▲ Buy | Grant | 67,550 | — | 4/1/2024 |
| CAUTREELS WERNER | ▲ Buy | Grant | 200,000 | — | 4/1/2024 |
| Pauza Charles David | ▲ Buy | Grant | 97,500 | — | 4/1/2024 |
| Redfield Robert | ▲ Buy | Grant | 97,500 | — | 4/1/2024 |
| Savchuk Nikolay | ▲ Buy | Grant | 885,532 | — | 4/1/2024 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 2,591 | $2K | 3/14/2024 |
| Fruchtman Steven M | ▼ Sell | Tax Withholding | 8,727 | $8K | 3/14/2024 |
| Fruchtman Steven M | ▲ Buy | Option Exercise | 23,111 | — | 3/13/2024 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 8,666 | — | 3/13/2024 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 6,900 | — | 2/7/2024 |
| Fruchtman Steven M | ▲ Buy | Option Exercise | 21,320 | — | 2/7/2024 |
| Fruchtman Steven M | ▼ Sell | Tax Withholding | 9,212 | $6K | 2/7/2024 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 2,443 | $2K | 2/7/2024 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 1,422 | $1K | 8/3/2023 |
| Fruchtman Steven M | ▼ Sell | Tax Withholding | 4,744 | $5K | 8/3/2023 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 4,750 | — | 8/2/2023 |
| Fruchtman Steven M | ▲ Buy | Option Exercise | 12,567 | — | 8/2/2023 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 5,500 | — | 6/12/2023 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 1,575 | $2K | 6/12/2023 |
| Fruchtman Steven M | ▼ Sell | Tax Withholding | 6,977 | $9K | 2/7/2023 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 6,900 | — | 2/7/2023 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 1,785 | $2K | 2/7/2023 |
| Gelder Mark S. MD | ▲ Buy | Option Exercise | 5,833 | — | 2/7/2023 |
| Fruchtman Steven M | ▲ Buy | Option Exercise | 21,320 | — | 2/7/2023 |
| Gelder Mark S. MD | ▼ Sell | Tax Withholding | 1,242 | $2K | 2/7/2023 |
| Guerin Mark Patrick | ▼ Sell | Tax Withholding | 1,355 | $2K | 8/3/2022 |
| Gelder Mark S. MD | ▼ Sell | Tax Withholding | 1,135 | $1K | 8/3/2022 |
| Fruchtman Steven M | ▼ Sell | Tax Withholding | 4,562 | $6K | 8/3/2022 |
| Guerin Mark Patrick | ▲ Buy | Option Exercise | 4,750 | — | 8/2/2022 |
| Gelder Mark S. MD | ▲ Buy | Option Exercise | 4,650 | — | 8/2/2022 |
| Fruchtman Steven M | ▲ Buy | Option Exercise | 12,566 | — | 8/2/2022 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 1,500 | $3K | 1/28/2022 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 1,500 | $3K | 1/21/2022 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 1,500 | $3K | 1/14/2022 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 1,500 | $4K | 1/7/2022 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 1,000 | $3K | 11/19/2021 |
| OLER ABRAHAM N. | ▼ Sell | Other | 5,000 | $15K | 11/18/2021 |
| Gelder Mark S. MD | ▲ Buy | Open Market | 2,381 | $10K | 9/28/2021 |
| Fruchtman Steven M | ▲ Buy | Open Market | 2,381 | $10K | 9/28/2021 |
| MARINO JAMES J | ▲ Buy | Open Market | 5,952 | $25K | 9/28/2021 |
| OLER ABRAHAM N. | ▲ Buy | Open Market | 2,381 | $10K | 9/28/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Traws Pharma listed in Benzinga health care movers
Traws Pharma was included in Benzinga's recent lists of health care stocks moving in pre-market and after-market sessions. These mentions indicate that the stock experienced price volatility relative to its peers during those trading periods. The company's shares currently trade near the middle of their 52-week range, with an average analyst target of $1.00.
Traws Pharma listed in Benzinga health care movers. Traws Pharma was included in Benzinga's recent lists of health care stocks moving in pre-market and after-market sessions. These mentions indicate that the stock experienced price volatility relative to its peers during those trading periods. The company's shares currently trade near the middle of their 52-week range, with an average analyst target of $1.00.